LON:CTEC - ConvaTec Group Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 147.30 -3.10 (-2.06 %) (As of 12/10/2018 03:21 PM ET)Previous CloseGBX 150.40Today's RangeGBX 145.80 - GBX 150.3552-Week RangeGBX 181.40 - GBX 349.10Volume3.37 million shsAverage Volume5.44 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartDividendInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes. The company also provides a portfolio of wound dressings that include antimicrobial and foam dressings to manage chronic wounds comprising pressure, venous leg, and diabetic foot ulcers. In addition, it offers devices, accessories, and services consisting of Esteem+ one-piece and Natura+ two-piece advanced pouch ranges for people with an ostomy or stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. Further, the company provides continence and critical care products, including intermittent urinary catheters; advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and a range of disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, and gastroenterology tubes. Additionally, it offers disposable infusion sets to the suppliers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and a range of products to hospitals and the home healthcare sector. The company markets its products through internal sales force, distributors, wholesalers, hospitals, specialist medical stores, pharmacies, and homecare agencies. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 2008 and is headquartered in Reading, the United Kingdom. Receive CTEC News and Ratings via Email Sign-up to receive the latest news and ratings for CTEC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolLON:CTEC Previous Symbol CUSIPN/A Webwww.convatecgroup.com Phone44 11 8952 8100 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous Employees9,541 Outstanding SharesN/AMarket Cap£0.00 OptionableNot Optionable ConvaTec Group (LON:CTEC) Frequently Asked Questions What is ConvaTec Group's stock symbol? ConvaTec Group trades on the London Stock Exchange (LON) under the ticker symbol "CTEC." How often does ConvaTec Group pay dividends? What is the dividend yield for ConvaTec Group? ConvaTec Group announced a dividend on Thursday, August 2nd. Investors of record on Thursday, September 6th will be given a dividend of GBX 1.31 per share on Friday, October 12th. This represents a yield of 0.58%. The ex-dividend date of this dividend is Thursday, September 6th. This is an increase from ConvaTec Group's previous dividend of $0.04. The official announcement can be viewed at this link. View ConvaTec Group's Dividend History. What price target have analysts set for CTEC? 12 Wall Street analysts have issued 12-month price objectives for ConvaTec Group's shares. Their forecasts range from GBX 130 to GBX 249. On average, they anticipate ConvaTec Group's share price to reach GBX 196.75 in the next twelve months. This suggests a possible upside of 33.6% from the stock's current price. View Analyst Price Targets for ConvaTec Group. What is the consensus analysts' recommendation for ConvaTec Group? 12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last year. There are currently 2 sell ratings, 6 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for ConvaTec Group. Has ConvaTec Group been receiving favorable news coverage? Press coverage about CTEC stock has been trending very positive this week, according to InfoTrie. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ConvaTec Group earned a news impact score of 3.9 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next several days. Who are some of ConvaTec Group's key competitors? Some companies that are related to ConvaTec Group include Activecare (ACAR), Advanced Oncotherapy (AVO), Airware Labs (AIRW), Anteo Diagnostics (ADO), Aurora Spine (ASG), Avacta Group (AVCT), Azure Healthcare (AZV), Biosig Technologies (BSGM), Cannabix Technologies (BLOZF), Cochlear (COH), Creo Medical Group (CREO), Draegerwerk AG & Co KGaA (DRW3), Electromed (ELMD), Ellex Medical Lasers (ELXMF) and Fisher & Paykel Healthcare (FPH). Who are ConvaTec Group's key executives? ConvaTec Group's management team includes the folowing people: Mr. Rick D. Anderson, Interim CEO & Non-Exec. Director (Age 57)Mr. Frank M. Schulkes, CFO & Director (Age 56)Mr. John Crosse, VP of Investor RelationsMr. Adam B. Deutsch, Exec. VP of Corp. Devel. & Gen. CounselMr. Douglas Le Fort, Sr. VP of Corp. Devel. (Age 52) How do I buy shares of ConvaTec Group? Shares of CTEC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is ConvaTec Group's stock price today? One share of CTEC stock can currently be purchased for approximately GBX 147.30. What is ConvaTec Group's official website? The official website for ConvaTec Group is http://www.convatecgroup.com. How can I contact ConvaTec Group? ConvaTec Group's mailing address is 3 Forbury Place Floor 7, 23 Forbury Road, ICKENHAM, RG1 3JH, United Kingdom. The company can be reached via phone at 44 11 8952 8100. MarketBeat Community Rating for ConvaTec Group (LON CTEC)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 209 (Vote Outperform)Underperform Votes: 222 (Vote Underperform)Total Votes: 431MarketBeat's community ratings are surveys of what our community members think about ConvaTec Group and other stocks. Vote "Outperform" if you believe CTEC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CTEC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/10/2018 by MarketBeat.com StaffFeatured Article: What is Liquidity?